BCT RESEARCHER RANKED AMONG TOP 1% OF WORLD’S RESEARCHERS

Breast Cancer Trials researcher Professor Sherene Loi is among the world’s most Highly Cited Researchers, according to the Highly Cited Researchers 2019 list from the Web of Science Group.

The highly anticipated list identifies scientists and social scientists who produced multiple papers ranking in the top 1% by citations for their field and year of publication, demonstrating significant research influence among their peers.

Professor Loi is a medical oncologist specialising in the treatment of breast cancer and a clinical scientist who leads the Translational Breast Cancer Genomics and Therapeutics Laboratory at the Peter MacCallum Cancer Centre. Her research team is internationally recognised for its use of genomic and immunological approaches to understand mechanisms of breast cancer growth and drug resistance.

Professor Loi is on the Breast Cancer Trials Scientific Advisory Committee and is the study chair of two BCT clinical trials, CHARIOT and DIAmOND.

• The DIAmOND clinical trial is examining a new immunotherapy treatment for patients with metastatic HER2 positive breast cancer. It is investigating the addition of two immune monoclonal antibodies (durvalumab and tremelimumab) to Herceptin.
• The CHARIOT clinical trials is evaluating whether the addition of two immunotherapy drugs (ipilimumab and nivolumab) to standard treatment, can improve the survival of women and men with high risk triple negative breast cancer. 

This year, the list includes 23 Nobel laureates among 6,217 Highly Cited Researchers in various fields from nearly 60 nations.

The number of Australian researchers recognised as Highly Cited has more than tripled in six years, from 80 in 2014 to 271 in 2019.

This is the second year Professor Loi has been named a Highly Cited Researcher. She was also recognised as Highly Cited in 2018.

Our life-saving breast cancer research is only possible thanks to the continued generosity of our supporters. Please help continue this vital work by making a donation today.